Both drugs, widely used in clinical practice, have specific considerations that healthcare providers must be aware of to prevent adverse effects and optimize therapeutic outcomes
Diabetes Care 25:13981404 Fonseca V, Baron M, Shao Q, Dejager S (2008) Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus
Los GLP-1 no representan una solucin nica ni inmediata, pero s un avance relevante dentro del manejo moderno del hgado graso
Giugliano D, Longo M, Scappaticcio L, et al
However, the emergence of newer treatments and increased competition have impacted its sales performance